Long
For adToken Is Easy To Print 260%+, Chart Mapped!
We've been looking at adToken for a while now and recently we are active with a trade.
The setup/bullish chart we were looking at is ready to pay...
We have prices moving above EMA10 and now trading above EMA50 while pushing higher... The RSI is at 57/strong.
adToken (ADTBTC) is a low volume altcoin pair and mid- to long-term it can produce amazing gains.
Remember to always have a plan/strategy before you trade.
Thanks a lot for your support.
Namaste.
The setup/bullish chart we were looking at is ready to pay...
We have prices moving above EMA10 and now trading above EMA50 while pushing higher... The RSI is at 57/strong.
adToken (ADTBTC) is a low volume altcoin pair and mid- to long-term it can produce amazing gains.
Remember to always have a plan/strategy before you trade.
Thanks a lot for your support.
Namaste.
Uwaga
Long-term chart | 10,000% PProfits to ATH (100X)Uwaga
Starting to move up with volume coming in...
🚨 LIFETIME (Pay 1, Get 7)
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
Powiązane publikacje
Wyłączenie odpowiedzialności
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 LIFETIME (Pay 1, Get 7)
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
Powiązane publikacje
Wyłączenie odpowiedzialności
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.